Thermal Titration Molecular Dynamics (TTMD): Not Your Usual Post-Docking Refinement

被引:16
作者
Menin, Silvia [1 ]
Pavan, Matteo [1 ]
Salmaso, Veronica [1 ]
Sturlese, Mattia [1 ]
Moro, Stefano [1 ]
机构
[1] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Mol Modeling Sect MMS, Via F Marzolo 5, I-35131 Padua, Italy
关键词
docking; refinement; rescoring; molecular dynamics; protein-ligand interaction fingerprints; thermal titration molecular dynamics; TTMD; CASEIN KINASE; SIMULATIONS; DESIGN;
D O I
10.3390/ijms24043596
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular docking is one of the most widely used computational approaches in the field of rational drug design, thanks to its favorable balance between the rapidity of execution and the accuracy of provided results. Although very efficient in exploring the conformational degrees of freedom available to the ligand, docking programs can sometimes suffer from inaccurate scoring and ranking of generated poses. To address this issue, several post-docking filters and refinement protocols have been proposed throughout the years, including pharmacophore models and molecular dynamics simulations. In this work, we present the first application of Thermal Titration Molecular Dynamics (TTMD), a recently developed method for the qualitative estimation of protein-ligand unbinding kinetics, to the refinement of docking results. TTMD evaluates the conservation of the native binding mode throughout a series of molecular dynamics simulations performed at progressively increasing temperatures with a scoring function based on protein-ligand interaction fingerprints. The protocol was successfully applied to retrieve the native-like binding pose among a set of decoy poses of drug-like ligands generated on four different pharmaceutically relevant biological targets, including casein kinase 1 delta, casein kinase 2, pyruvate dehydrogenase kinase 2, and SARS-CoV-2 main protease.
引用
收藏
页数:22
相关论文
共 73 条
  • [1] Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases
    Akaki, Tatsuo
    Bessho, Yuki
    Ito, Takashi
    Fujioka, Shingo
    Ubukata, Minoru
    Mori, Genki
    Yamanaka, Kenji
    Orita, Takuya
    Doi, Satoki
    Iwanaga, Tomoko
    Ikegashira, Kazutaka
    Hantani, Yoshiji
    Nakanishi, Isao
    Adachi, Tsuyoshi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 44
  • [2] Combining docking and molecular dynamic simulations in drug design
    Alonso, Hernan
    Bliznyuk, Andrey A.
    Gready, Jill E.
    [J]. MEDICINAL RESEARCH REVIEWS, 2006, 26 (05) : 531 - 568
  • [3] The process of structure-based drug design
    Anderson, AC
    [J]. CHEMISTRY & BIOLOGY, 2003, 10 (09): : 787 - 797
  • [4] The Implications of PDK1-4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
    Atas, Emine
    Oberhuber, Monika
    Kenner, Lukas
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335
  • [6] Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer
    Battistutta, Roberto
    Cozza, Giorgio
    Pierre, Fabrice
    Papinutto, Elena
    Lolli, Graziano
    Sarno, Stefania
    O'Brien, Sean E.
    Siddiqui-Jain, Adam
    Haddach, Mustapha
    Anderes, Kenna
    Ryckman, David M.
    Meggio, Flavio
    Pinna, Lorenzo A.
    [J]. BIOCHEMISTRY, 2011, 50 (39) : 8478 - 8488
  • [7] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [8] Protein kinase CK2: a potential therapeutic target for diverse human diseases
    Borgo, Christian
    D'Amore, Claudio
    Sarno, Stefania
    Salvi, Mauro
    Ruzzene, Maria
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [9] Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase
    Brough, Paul A.
    Baker, Lisa
    Bedford, Simon
    Brown, Kirsten
    Chavda, Seema
    Chell, Victoria
    D'Alessandro, Jalanie
    Davies, Nicholas G. M.
    Davis, Ben
    Le Strat, Loic
    Macias, Alba T.
    Maddox, Daniel
    Mahon, Patrick C.
    Massey, Andrew J.
    Matassova, Natalia
    McKenna, Sean
    Meissner, Johannes W. G.
    Moore, Jonathan D.
    Murray, James B.
    Northfield, Christopher J.
    Parry, Charles
    Parsons, Rachel
    Roughley, Stephen D.
    Shaw, Terry
    Simmonite, Heather
    Stokes, Stephen
    Surgenor, Allan
    Stefaniak, Emma
    Robertson, Alan
    Wang, Yikang
    Webb, Paul
    Whitehead, Neil
    Wood, Mike
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) : 2271 - 2286
  • [10] Case D.A., AMBERTOOLS22